Aldeyra Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-43.2M | $-43.2M | — | $8.0M |
| FY2025 | $-33.3M | $-33.3M | — | $6.1M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-43.2M | $-43.2M | — | $8.0M |
| FY2025 | $-33.3M | $-33.3M | — | $6.1M |